The in vitro and in vivo antiviral properties of combined monoterpene alcohols against West Nile virus infection. (Q38772810)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27152479%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

title

The in vitro and in vivo antiviral properties of combined monoterpene alcohols against West Nile virus infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27152479%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

0 references

Adriana Pliego Zamora

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27152479%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Alexander A. Khromykh

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27152479%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Stephen J. Ralph

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27152479%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

author name string

Judith H Edmonds

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27152479%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Maxwell J Reynolds

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27152479%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

language of work or name

English

0 references

publication date

3 May 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27152479%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27152479%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

volume

495

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27152479%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

page(s)

18-32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27152479%20AND%20SRC:MED&resulttype=core&format=json

Comparative study on the antiviral activity of selected monoterpenes derived from essential oils

4 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Virulence determinants between New York 99 and Kunjin strains of West Nile virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Use of RNA interference to prevent lethal murine west nile virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Economic burden of West Nile virus in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Infectious disease. Combating emerging viral threats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Novel approaches to flavivirus drug discovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Zika Virus Outbreak, Bahia, Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Melaleuca alternifolia (Tea Tree) oil: a review of antimicrobial and other medicinal properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Rodent models for the study of therapy against flavivirus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Avian reovirus nonstructural protein p17-induced G(2)/M cell cycle arrest and host cellular protein translation shutoff involve activation of p53-dependent pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Natural products: a continuing source of novel drug leads

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

The naturally attenuated Kunjin strain of West Nile virus shows enhanced sensitivity to the host type I interferon response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Inhibition of flavivirus infections by antisense oligomers specifically suppressing viral translation and RNA replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Statins inhibit HIV-1 infection by down-regulating Rho activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Progress on the development of therapeutics against West Nile virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Evasion of innate and adaptive immunity by flaviviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Pathogenesis of flavivirus infections: using and abusing the host cell

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Activity of Melaleuca alternifolia (tea tree) oil on Influenza virus A/PR/8: study on the mechanism of action.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Regulation of the mevalonate pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

7 January 2021

Pathogenic flaviviruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Zika virus outside Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

S-phase-dependent enhancement of dengue virus 2 replication in mosquito cells, but not in human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Dengue virus therapeutic intervention strategies based on viral, vector and host factors involved in disease pathogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

The Src Family Kinase c-Yes Is Required for Maturation of West Nile Virus Particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

A new insect-specific flavivirus from northern Australia suppresses replication of West Nile virus and Murray Valley encephalitis virus in co-infected mosquito cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Synchronization of the cell cycle using lovastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Regulatory challenges: lessons from recent West Nile virus trials in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Niclosamide is a proton carrier and targets acidic endosomes with broad antiviral effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Use of interferon-alpha in patients with West Nile encephalitis: report of 2 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Targeting host factors to treat West Nile and dengue viral infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

A single siRNA suppresses fatal encephalitis induced by two different flaviviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Lycorine reduces mortality of human enterovirus 71-infected mice by inhibiting virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Immunomodulatory activity of Melaleuca alternifolia concentrate (MAC): inhibition of LPS-induced NF-κB activation and cytokine production in myeloid cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Cholesterol manipulation by West Nile virus perturbs the cellular immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Statins reduce dengue virus production via decreased virion assembly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

In vivo activity of terpinen-4-ol, the main bioactive component of Melaleuca alternifolia Cheel (tea tree) oil against azole-susceptible and -resistant human pathogenic Candida species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Humanized monoclonal antibody against West Nile virus envelope protein administered after neuronal infection protects against lethal encephalitis in hamsters.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Identification of Novel Small-Molecule Inhibitors of West Nile Virus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

West Nile virus-induced bax-dependent apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Role of host cell factors in flavivirus infection: Implications for pathogenesis and development of antiviral drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Better late than never: antivirals for dengue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Effect of interferon-alpha2b therapy on St. Louis viral meningoencephalitis: clinical and laboratory results of a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Role of reactive oxygen intermediates in Japanese encephalitis virus infection in murine neuroblastoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Molecular targets for flavivirus drug discovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Pathogenesis of West Nile Virus Infection: a Balance between Virulence, Innate and Adaptive Immunity, and Viral Evasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Experimental Usutu virus infection of suckling mice causes neuronal and glial cell apoptosis and demyelination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Induction of inflammation by West Nile virus capsid through the caspase-9 apoptotic pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

Animal models of dengue virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.021

10.1016/J.VIROL.2016.04.021

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27152479%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

1 reference